Feasibility of acute thrombolytic therapy for stroke

Neurology India

Volumn 51, Issue 4, 2003, Pages 470-473

  Nandigam, K ^a   Narayan, Sunil K ^a   Elangovan, S ^a   Dutta, T K ^a   Sethuraman, K R ^a   Das, A K ^a  

^a Jawaharlal Institute   (India)

Author keywords

Rural India; Stroke; Thrombolytic therapy

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; ADULT; ARTICLE; AWARENESS; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HUMAN; INDIA; INDIAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PATIENT TRANSPORT; PHYSICIAN; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; REGISTER; RESIDENTIAL CARE; RURAL AREA; RURAL HEALTH CARE; SOCIAL STATUS; TIME; TREATMENT CONTRAINDICATION; UNIVERSITY HOSPITAL;

ACUTE DISEASE; CEREBROVASCULAR ACCIDENT; FEASIBILITY STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INDIA; MALE; MIDDLE AGED; REGISTRIES; RURAL HEALTH SERVICES; THROMBOLYTIC THERAPY;

EID: 1042303670     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tissue plasminogen activator for acute ischemic stroke. The national Institute of Neurological Disorders and Stroke. rt-PA stroke study group, N Eng J Med 1995;333:1581-7.
2. Hacke W, Kaste M, Fieschi C. Intravenous thrombolysis with recombinant tissue plasminogen activator for hemispheric stroke. The European Cooperative acute stroke study (ECASS). JAMA 1995;274:1017-25.
3. NINDS rTPA stroke study group: A systems approach to immediate evaluation and management of hyper acute stroke. Stroke 1997;28:1530-40.
4. Thrombolytic therapy with streptokinase in acute ischemic stroke. The multicentre acute stroke trial- Europe study group. N Eng J Med 1996;335: 145-50.
5. Donnan GA, Davis SM, Chambers BR. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian streptokinase (ASK) Trial study Group. JAMA 1996;276:961-6.
6. Barber PA, Darby DG, Desmond PM. Identification of major ischemic change. Diffusion weighted imaging versus computed tomography. Stroke 1999;30: 2059-65.
7. Koroshetz WJ, Lev MH. Contrast computed tomography scan in acute stroke: Ann Neurol 2002;51:415-6.
8. Larrue V, Von Kummer RR, Muloer A. Risk factors for severe, hemorrhagic transformation in ischemic, stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the, European- Australasian acute stroke study (ECASS -II). Stroke 2001;32:438-41.
9. Albers GW, Clark WM, Maden KP. ATLANTIS trial results for patients treated within 3 hours of stroke onset. Stroke 2002;33:493-6.
10. Lopez -Yunaz AM, Bruno A, Williams LS. Protocol violations in community based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 2001;32:12-5.
11. Marler JR, Tiley BC, Lu M. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55:1649-55.
12. Katzan IL, Sila CA, Furlan AJ. Community use of intravenous tissue plasminogen activator for acute stroke results of brain matters stroke management survey. Stroke 2001;32:861-5.
13. Merino JG, Silver B, Wong E. Extending rTPA use to community and rural stroke patients. Stroke 2002;33:141-6.
14. Lacy CR, Suh DC, Bueno M, Delay in presentation and evaluation for acute stroke: stroke time registry for outcomes knowledge and epidemiology (stroke). Stroke 2001;32:63-9.
15. Adams HP, Brott TG, Furlan AJ. Guidelines for thrombolytic therapy for acute stroke. Circulation 94:1167-74.